Preparation, in vitro and in vivo evaluation of a novel mitiglinide microemulsions

This study aimed to prepare an o/w mitiglinide microemulsion (MTGME) to improve the drug solubility and bioavailability. The formulation of o/w MTGME was optimized by the solubility study of drug, pseudo-ternary phase diagram and Box-Behnken design successively. MTGME was characterized by dynamic la...

Full description

Bibliographic Details
Main Authors: Miaomiao Wang, Hanghang Li, Wenzhi Yang
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Saudi Pharmaceutical Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016423004140
_version_ 1827344844137168896
author Miaomiao Wang
Hanghang Li
Wenzhi Yang
author_facet Miaomiao Wang
Hanghang Li
Wenzhi Yang
author_sort Miaomiao Wang
collection DOAJ
description This study aimed to prepare an o/w mitiglinide microemulsion (MTGME) to improve the drug solubility and bioavailability. The formulation of o/w MTGME was optimized by the solubility study of drug, pseudo-ternary phase diagram and Box-Behnken design successively. MTGME was characterized by dynamic laser light scattering (DLS), zeta potential and transmission electron microscopy (TEM), moreover, the storage stability, pharmacodynamics and pharmacokinetics were investigated. The optimal prescription for MTGME consisted of Maisine 35–1 (oil), Cremophor EL (surfactant) and propylene glycol (PG, cosurfactant). MTGME with a spherical dimension of 58.1 ± 5.86 nm was stable when stored at 4 °C for 3 months. The blood glucose levers (BGL) of diabetic mice were uniformly and significantly decreased by intragastric (i.g.) administration of 1–4 mg/kg MTGME, in which BGL (i.g. 4 mg/kg MTGME) was reduced by 69% during 24 h. The pharmacokinetics study of MTGME (i.g., 20 mg/kg) in Wistar rats showed higher plasma drug concentration (Cmax, 2.9 folds), larger area under curve (AUC, 4.6 folds) and oral bioavailability than those of MTG suspensions. Generally, the MTGME (o/w) showed good effect on controlling hyperglycemia. Therefore, microemulsion can be used as an effective oral drug delivery system to improve the bioavailability of MTG.
first_indexed 2024-03-07T22:55:26Z
format Article
id doaj.art-8d12f984a39c43e1afeadeb8d82404c2
institution Directory Open Access Journal
issn 1319-0164
language English
last_indexed 2024-03-07T22:55:26Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Saudi Pharmaceutical Journal
spelling doaj.art-8d12f984a39c43e1afeadeb8d82404c22024-02-23T04:58:44ZengElsevierSaudi Pharmaceutical Journal1319-01642024-01-01321101919Preparation, in vitro and in vivo evaluation of a novel mitiglinide microemulsionsMiaomiao Wang0Hanghang Li1Wenzhi Yang2Department of Pharmacy, Baoding NO. 1 Central Hospital, Baoding Great Wall North Street No. 320, Hebei Province, Baoding 071000, ChinaKey Laboratory of Pharmaceutical Quality Control of Hebei Province & College of Pharmaceutical Science, Hebei University, Baoding 071002, ChinaKey Laboratory of Pharmaceutical Quality Control of Hebei Province & College of Pharmaceutical Science, Hebei University, Baoding 071002, China; Corresponding author at: Hebei University, 180 East Wusi Road, Baoding, Hebei Province 071002, China.This study aimed to prepare an o/w mitiglinide microemulsion (MTGME) to improve the drug solubility and bioavailability. The formulation of o/w MTGME was optimized by the solubility study of drug, pseudo-ternary phase diagram and Box-Behnken design successively. MTGME was characterized by dynamic laser light scattering (DLS), zeta potential and transmission electron microscopy (TEM), moreover, the storage stability, pharmacodynamics and pharmacokinetics were investigated. The optimal prescription for MTGME consisted of Maisine 35–1 (oil), Cremophor EL (surfactant) and propylene glycol (PG, cosurfactant). MTGME with a spherical dimension of 58.1 ± 5.86 nm was stable when stored at 4 °C for 3 months. The blood glucose levers (BGL) of diabetic mice were uniformly and significantly decreased by intragastric (i.g.) administration of 1–4 mg/kg MTGME, in which BGL (i.g. 4 mg/kg MTGME) was reduced by 69% during 24 h. The pharmacokinetics study of MTGME (i.g., 20 mg/kg) in Wistar rats showed higher plasma drug concentration (Cmax, 2.9 folds), larger area under curve (AUC, 4.6 folds) and oral bioavailability than those of MTG suspensions. Generally, the MTGME (o/w) showed good effect on controlling hyperglycemia. Therefore, microemulsion can be used as an effective oral drug delivery system to improve the bioavailability of MTG.http://www.sciencedirect.com/science/article/pii/S1319016423004140Mitiglinide microemulsionBioavailabilityPharmacodynamicsPharmacokinetics
spellingShingle Miaomiao Wang
Hanghang Li
Wenzhi Yang
Preparation, in vitro and in vivo evaluation of a novel mitiglinide microemulsions
Saudi Pharmaceutical Journal
Mitiglinide microemulsion
Bioavailability
Pharmacodynamics
Pharmacokinetics
title Preparation, in vitro and in vivo evaluation of a novel mitiglinide microemulsions
title_full Preparation, in vitro and in vivo evaluation of a novel mitiglinide microemulsions
title_fullStr Preparation, in vitro and in vivo evaluation of a novel mitiglinide microemulsions
title_full_unstemmed Preparation, in vitro and in vivo evaluation of a novel mitiglinide microemulsions
title_short Preparation, in vitro and in vivo evaluation of a novel mitiglinide microemulsions
title_sort preparation in vitro and in vivo evaluation of a novel mitiglinide microemulsions
topic Mitiglinide microemulsion
Bioavailability
Pharmacodynamics
Pharmacokinetics
url http://www.sciencedirect.com/science/article/pii/S1319016423004140
work_keys_str_mv AT miaomiaowang preparationinvitroandinvivoevaluationofanovelmitiglinidemicroemulsions
AT hanghangli preparationinvitroandinvivoevaluationofanovelmitiglinidemicroemulsions
AT wenzhiyang preparationinvitroandinvivoevaluationofanovelmitiglinidemicroemulsions